By Kamal Choudhury (Reuters) -Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S.

The report, to be released Thursday, is expected to identify the key drivers of chronic childhood illness, such as asthma and ...

Zimlovisertib plus tofacitinib shows greater efficacy than tofacitinib alone in reducing Disease Activity Scores in patients ...

Baseline tumor-infiltrating lymphocytes and positive nodes can help identify women with TMBC at high risk for relapse despite ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...

Power Grid Corporation of India, DLF, Pfizer, New India Assurance, NLC India, and Gujarat Gas are among 104 companies that ...

Metro Loft and David Werner’s secured $720 million of construction financing to execute New York City’s largest office-resi ...

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...

Research indicates that high-yield stock portfolios outperform over time. Does your portfolio have the right mix of ...

China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...